Clinical Trial Update: Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Endostar in combination with corticosteroids for radiation-induced brain necrosis in nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Jiangxi Provincial Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN